Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 122
Filter
1.
Arch Pediatr ; 30(5): 307-313, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37236887

ABSTRACT

BACKGROUND: Collagen gastritis is a rare disease that manifests in children mainly as isolated gastric involvement associated with martial deficiency anemia. There are no recommendations for the management and follow-up of these patients. We aimed to describe the clinical data, endoscopic findings, and treatments deployed in France's children with collagenous gastritis. METHODS: All French pediatric gastroenterology centers and pediatric centers for rare digestive diseases (Centres de Maladies Rares Digestives) were contacted to collect cases of collagenous gastritis, defined on gastric biopsies and diagnosed before 18 years of age. RESULTS: A total of 12 cases diagnosed (4 males and 8 females) between 1995 and 2022 could be analyzed. The median age at diagnosis was 12.5 years (7-15.2). The most frequent clinical presentation was abdominal pain (6/11) and/or nonspecific symptomatology attributed to anemia (8/10). Anemia was present in all children (11/11; Hb 2.8-9.1 g/dL). Nodular gastritis was present in 10 patients (antrum: 2; fundus: 4; in antrum and fundus: 4). All patients had a basement membrane thickening (from 19 to 100 µm). The treatments received were PPI (11), oral or intravenous martial supplementation (12), budesonide (1), and prednisone (1). Martial supplementation improved anemia in all cases. At discontinuation, nine of 10 patients had a recurrence of anemia. CONCLUSION: Collagenous gastritis is an exceptional condition, clinically manifested in children as abdominal pain and iron deficiency anemia probably of hemorrhagic origin. Patients require long-term follow-up and monitoring of their disease to describe the risk of progression better.


Subject(s)
Anemia , Gastritis , Malabsorption Syndromes , Male , Female , Humans , Child , Gastritis/complications , Gastritis/diagnosis , Gastritis/therapy , Biopsy , Malabsorption Syndromes/complications , Anemia/complications , Abdominal Pain/etiology
2.
Arch Pediatr ; 30(6): 355-360, 2023 Aug.
Article in English | MEDLINE | ID: mdl-37147153

ABSTRACT

BACKGROUND: Each year, new pediatric residents begin their shifts in the pediatric emergency room. While technical skills are often acquired during workshops, non-technical skills such as communication, professionalism, situational awareness, or decision-making are rarely tested. Simulation enables non-technical skills to be developed in situations frequently encountered in pediatric emergencies. Adopting an innovative approach, we combined two pedagogical methods: the Script Concordance Test (SCT) and simulation to improve clinical reasoning and non-technical skills of first-year pediatric residents in dealing with clinical situations involving febrile seizures. The aim of this work is to report the feasibility of such a combined training. METHODS: The first-year pediatric residents participated in a training session on how to manage a child attending the emergency department with a febrile seizure. At the beginning of the session, the trainees had to complete the SCT (seven clinical situations) and then participated in three simulation scenarios. Student satisfaction was assessed by means of a questionnaire at the end of the session. RESULTS: In this pilot study, 20 residents participated in the training. The SCT scores for the first-year pediatric residents were lower and more widely distributed than those of the experts with better concordance for diagnostic items compared to investigation or treatment items. All were satisfied with the teaching methods employed. Further sessions on additional topics relating to the management of pediatric emergency cases were requested. CONCLUSION: Although limited by the small size of our study, this combination of teaching methods was possible and seemed promising for the development of non-technical skills of pediatric residents. These methods are in line with the changes being made to the third cycle of medical studies in France and can be adapted to other situations and other specialties.


Subject(s)
Internship and Residency , Humans , Child , Pilot Projects , Clinical Competence , Educational Measurement/methods , Clinical Decision-Making
3.
J Pediatr Gastroenterol Nutr ; 75(3): 356-368, 2022 09 01.
Article in English | MEDLINE | ID: mdl-35706093

ABSTRACT

Excluding oligo-, di-, monosaccharides and polyols (FODMAPs) from the diet is increasingly being used to treat children with gastrointestinal complaints. The aim of this position paper is to review the available evidence on the safety and efficacy of its use in children and provide expert guidance regarding practical aspects in case its use is considered . Members of the Gastroenterology Committee, the Nutrition Committee and the Allied Health Professionals Committee of the European Society for Pediatric Gastroenterology Hepatology and Nutrition contributed to this position paper. Clinical questions regarding initiation, introduction, duration, weaning, monitoring, professional guidance, safety and risks of the diet are addressed. A systematic literature search was performed from 2005 to May 2021 using PubMed, MEDLINE and Cochrane Database of Systematic Reviews. In the absence of evidence, recommendations reflect the expert opinion of the authors. The systematic literature search revealed that the low-FODMAP diet has not been comprehensively studied in children. Indications and contraindications of the use of the diet in different pediatric gastroenterological conditions are discussed and practical recommendations are formulated. There is scarce evidence to support the use of a low-FODMAP diet in children with Irritable Bowel Syndrome and no evidence to recommend its use in other gastrointestinal diseases and complaints in children. Awareness of how and when to use the diet is crucial, as a restrictive diet may impact nutritional adequacy and/or promote distorted eating in vulnerable subjects. The present article provides practical safety tips to be applied when the low-FODMAP diet is considered in children.


Subject(s)
Gastroenterology , Irritable Bowel Syndrome , Child , Diet , Diet, Carbohydrate-Restricted , Disaccharides , Fermentation , Humans , Monosaccharides , Oligosaccharides , Systematic Reviews as Topic
4.
Arch Pediatr ; 28(2): 105-110, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33341334

ABSTRACT

Celiac disease (CD) is an immune-mediated systemic disorder caused by ingestion of the gluten found in wheat, rye, and barley. The currently estimated prevalence in children is about 1%. CD is a chronic enteropathy with gastrointestinal manifestations including diarrhea, abdominal distension and weight loss, but extra-intestinal features are increasingly being reported. Dental and oral manifestations such as dental enamel defects (ED), delay in dental eruption, and recurrent aphthous stomatitis (RAS) are well-recognized manifestations of CD. The aim of this study was to compare the frequency of oral manifestations (ED, RAS and delay in dental eruption) on deciduous and permanent teeth between children with CD and a control population. An oral examination was performed on 28 CD children and 59 control children. All children were younger than 12 years old and had deciduous or mixed dentition. CD children had significantly more ED and RAS than the control group (67.9% vs. 33.9% P=0.004 and 50.0% vs. 21.8% P=0.011, respectively). No delay in dental eruption was observed in CD children. ED were mainly grade I and II of Aine's classification (color defects and slight structural defects). ED were more often seen on CD children's deciduous teeth than on permanent teeth (57.1% and 13.6%, respectively; P<0.001). The main teeth affected by ED are the second molar and canines of the deciduous teeth, and the first molar, central incisor, and lateral incisors of the permanent teeth. RAS and ED that were symmetrical in all quadrants and occurred firstly in teeth that mineralize during the first year of life both seem to be signs of CD. Thus, more information for dentists and pediatricians on these oral manifestations should help improve detection of CD.


Subject(s)
Celiac Disease/complications , Stomatitis, Aphthous/etiology , Tooth Diseases/etiology , Case-Control Studies , Celiac Disease/diagnosis , Child , Child, Preschool , Female , Follow-Up Studies , France , Humans , Infant , Male , Prevalence , Prospective Studies , Risk Factors , Stomatitis, Aphthous/diagnosis , Stomatitis, Aphthous/epidemiology , Tooth Diseases/diagnosis , Tooth Diseases/epidemiology
5.
Rev Mal Respir ; 37(5): 355-363, 2020 May.
Article in French | MEDLINE | ID: mdl-32334966

ABSTRACT

INTRODUCTION: Chest computed tomography (CT) is essential to monitor lung disease in children with cystic fibrosis, but it involves recurrent exposure to ionizing radiation. The aim of this study was to compare the current complete CT protocol (volumetric end-inspiratory plus sequential expiratory acquisition) to a sequential expiratory acquisition protocol alone in terms of image analysis and ionizing radiation dose. METHODS: Seventy-eight CT scans from 57 children aged 5 to 18 years old were scored on the complete protocol images and on the expiratory sequential images only. Each CT protocol was scored independently, using the Brody scoring system, by two paediatric radiologists. RESULTS: Correlations between the Brody global scores of the two different CT protocols were very good (r=0.90 for both observers), for the bronchiectasis score (r=0.72 and 0.86), mucus plugging score (r=0.87 and 0.83), and expiratory trapped air (r=0.96 and 0.92). Total ionizing radiation dose was reduced, with the measured dose length product (DLP) reduced from 103.31mGy.cm (complete protocol) to 3.06mGy.cm (expiratory protocol) (P<0.001). CONCLUSION: An expiratory chest CT protocol was accurate in diagnosing early signs of CF disease and permitted significant reduction of radiation dose. This protocol would allow spacing out of complete CT scanning with its higher radiation dose and should be considered for the monitoring of lung disease severity in children with CF.


Subject(s)
Cystic Fibrosis/diagnosis , Exhalation/physiology , Monitoring, Physiologic/methods , Occupational Exposure/prevention & control , Radiation Dosage , Tomography, X-Ray Computed , Adolescent , Child , Child, Preschool , Cohort Studies , Cross-Sectional Studies , Cystic Fibrosis/physiopathology , Female , Humans , Male , Occupational Exposure/adverse effects , Prognosis , Radiography, Thoracic/adverse effects , Radiography, Thoracic/methods , Respiration , Respiratory Function Tests , Retrospective Studies , Tomography, X-Ray Computed/adverse effects , Tomography, X-Ray Computed/methods
6.
J Crohns Colitis ; 14(8): 1119-1148, 2020 Sep 07.
Article in English | MEDLINE | ID: mdl-32115645

ABSTRACT

BACKGROUND AND AIMS: Inflammatory bowel disease [IBD] is often one of the most devastating and debilitating chronic gastrointestinal disorders in children and adolescents. The main objectives here were to systematically review the incidence and prevalence of paediatric IBD across all 51 European states. METHODS: We undertook a systematic review and meta-analysis based on PubMed, CINAHL, the Cochrane Library, searches of reference lists, grey literature and websites, covering the period from 1970 to 2018. RESULTS: Incidence rates for both paediatric Crohn's disease [CD] and ulcerative colitis [UC] were higher in northern Europe than in other European regions. There have been large increases in the incidence of both paediatric CD and UC over the last 50 years, which appear widespread across Europe. The largest increases for CD have been reported from Sweden, Wales, England, the Czech Republic, Denmark and Hungary, and for UC from the Czech Republic, Ireland, Sweden and Hungary. Incidence rates for paediatric CD have increased up to 9 or 10 per 100 000 population in parts of Europe, including Scandinavia, while rates for paediatric UC are often slightly lower than for CD. Prevalence reported for CD ranged from 8.2 per 100 000 to approximately 60 and, for UC, from 8.3 to approximately 30. CONCLUSIONS: The incidence of paediatric IBD continues to increase throughout Europe. There is stronger evidence of a north-south than an east-west gradient in incidence across Europe. Further prospective studies are needed, preferably multinational and based on IBD registries, using standardized definitions, methodology and timescales.


Subject(s)
Colitis, Ulcerative/epidemiology , Crohn Disease/epidemiology , Child , Europe/epidemiology , Humans , Incidence , Needs Assessment , Prevalence
7.
Arch Pediatr ; 26(7): 442-450, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31615715

ABSTRACT

The current craze for vegan diets has an effect on the pediatric population. This type of diet, which does not provide all the micronutrient requirements, exposes children to nutritional deficiencies. These can have serious consequences, especially when this diet is introduced at an early age, a period of significant growth and neurological development. Even if deficiencies have less impact on older children and adolescents, they are not uncommon and consequently should also be prevented. Regular dietary monitoring is essential, vitamin B12 and vitamin D supplementation is always necessary, while iron, calcium, docosahexaenoic acid, and zinc should be supplemented on a case-by-case basis.


Subject(s)
Diet, Vegan/standards , Malnutrition/prevention & control , Adolescent , Child , Diet, Vegan/adverse effects , Diet, Vegan/methods , Dietary Supplements/standards , France , Humans , Malnutrition/diagnosis , Malnutrition/etiology
9.
Article in English | MEDLINE | ID: mdl-29031390

ABSTRACT

BACKGROUND: Resolution of inflammation is an active process involving specialised pro-resolving mediators (SPMs) generated from the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Omega-3 fatty acid supplementation during infancy may provide an intervention strategy to modify SPMs and reduce oxidative stress. This study evaluates the effect of omega-3 fatty acid supplementation in infancy on SPMs and F2-isoprostanes from 6 months to 5 years of age. METHODS: In a double-blind, placebo-controlled, parallel-group study design, 420 infants were randomized to a daily supplement of omega-3 fatty acids (280mg DHA and 110mg EPA) or olive oil (control), from birth to age 6 months. Blood was collected at birth (cord blood), 6 months, 12 months and 5 years. Plasma SPMs included 18-HEPE, E-series resolvins, 17-HDHA, D-series resolvins, 14-HDHA, 10S,17S-DiHDoHE, MaR1 and PD1. F2-isoprostanes were measured in plasma and urine, as markers of oxidative stress in vivo. RESULTS: The change in the concentration of 18-HEPE from birth to 6 months was greater in the omega-3 fatty acid group (Ptimepoint*group=0.04) with levels at 6 months significantly higher than controls (P=0.02). Other SPMs were not different between the groups at any time point. Plasma 18-HEPE concentration were associated with erythrocyte EPA concentrations after age and group adjustments (P<0.001), but not with allergic outcomes at 12 months. There were no between-group differences in plasma and urinary F2-isoprostanes at any time point. CONCLUSION: Omega-3 fatty acid supplementation from birth to 6 months of age increased SPM at 6 months but the effects were not sustained after supplementation ceased. Given that 18-HEPE is a biologically active metabolite, future studies should examine how the increase in 18-HEPE relates to potential health benefits of omega-3 fatty acid supplementation in infancy.


Subject(s)
Biomarkers/blood , Fatty Acids, Omega-3/administration & dosage , Hydroxyeicosatetraenoic Acids/blood , Inflammation/blood , Child, Preschool , Dietary Supplements/adverse effects , Docosahexaenoic Acids/administration & dosage , Docosahexaenoic Acids/blood , Eicosapentaenoic Acid/administration & dosage , Eicosapentaenoic Acid/blood , Fatty Acids, Omega-3/adverse effects , Fatty Acids, Omega-3/blood , Female , Humans , Infant , Inflammation/physiopathology , Male , Olive Oil/administration & dosage , Oxidative Stress/drug effects , Pregnancy
10.
Article in English | MEDLINE | ID: mdl-27910234

ABSTRACT

BACKGROUND: The pathophysiology of infantile colic is poorly understood, though various studies report gut microbiota dysbiosis in colicky infants. We aimed to test the hypothesis that colic-related dysbiosis is associated with visceral hypersensitivity triggered by an altered luminal milieu. METHODS: Fecal samples from seven colicky and seven non-colicky infants were studied. Fecal supernatants (FS) were infused into the colons of C57/Bl6 mice (n=10/specimen). Visceral sensitivity was subsequently assessed in the animals by recording their abdominal muscle response to colorectal distension (CRD) by electromyography (EMG). Serine and cysteine protease activities were assessed in FS with specific substrates. Infant fecal microbiota composition was analyzed by DNA extraction and 16S rRNA gene pyrosequencing. KEY RESULTS: FS from colicky infants triggered higher EMG activity than FS from non-colicky infants in response to both the largest CRD volumes and overall, as assessed by the area under the curve of the EMG across all CRD volumes. Infant crying time strongly correlated with mouse EMG activity. Microbiota richness and phylogenetic diversity were increased in the colicky group, without showing prominent microbial composition alterations. Only Bacteroides vulgatus and Bilophila wadsworthia were increased in the colicky group. Bacteroides vulgatus abundance positively correlated with visceral sensitivity. No differences were found in protease activities. CONCLUSIONS & INFERENCES: Luminal contents from colicky infants trigger visceral hypersensitivity, which may explain the excessive crying behavior of these infants. Additional studies are required to determine the nature of the compounds involved, their mechanism of action, and the potential implications of intestinal microbiota in their generation.


Subject(s)
Colic/physiopathology , Feces , Gastrointestinal Tract/physiopathology , Visceral Pain/chemically induced , Visceral Pain/physiopathology , Animals , Colic/complications , Colon/microbiology , Colon/physiopathology , Electromyography/methods , Feces/microbiology , Gastrointestinal Tract/microbiology , Humans , Infant , Infant, Newborn , Male , Mice , Mice, Inbred C57BL
11.
Article in English | MEDLINE | ID: mdl-27637341

ABSTRACT

BACKGROUND: Oxidative stress and nutritional deficiency may influence the excessive shortening of the telomeric ends of chromosomes. It is known that stress exposure in intrauterine life can produce variations in telomere length (TL), thereby potentially setting up a long-term trajectory for disease susceptibility. OBJECTIVE: To assess the effect of omega-3 long chain polyunsaturated fatty acid (n-3 LCPUFA) supplementation during pregnancy on telomere length and oxidative stress in offspring at birth and 12 years of age (12y). DESIGN: In a double-blind, placebo-controlled, parallel-group study, 98 pregnant atopic women were randomised to 4g/day of n-3 LCPUFA or control (olive oil [OO]), from 20 weeks gestation until delivery. Telomere length as a marker of cell senescence and plasma and urinary F2-isoprostanes as a marker of oxidative stress were measured in the offspring at birth and 12y. RESULTS: Maternal n-3 LCPUFA supplementation did not influence offspring telomere length at birth or at 12y with no changes over time. Telomere length was not associated with F2-isoprostanes or erythrocyte total n-3 fatty acids. Supplementation significantly reduced cord plasma F2-isoprostanes (P<0.001), with a difference in the change over time between groups (P=0.05). However, the differences were no longer apparent at 12y. Between-group differences for urinary F2-isoprostanes at birth and at 12y were non-significant with no changes over time. CONCLUSIONS: This study does not support the hypothesis that n-3 LCPUFA during pregnancy provides sustained effects on postnatal oxidative stress and telomere length as observed in the offspring.


Subject(s)
F2-Isoprostanes/blood , F2-Isoprostanes/urine , Fatty Acids, Omega-3/administration & dosage , Telomere/drug effects , Child , Dietary Supplements , Double-Blind Method , Erythrocytes/chemistry , Fatty Acids, Omega-3/pharmacology , Female , Humans , Oxidative Stress/drug effects , Pregnancy , Prenatal Care
12.
Arch Pediatr ; 23(6): 570-6, 2016 Jun.
Article in French | MEDLINE | ID: mdl-27133367

ABSTRACT

Feeding disorders and food refusal can be found in 25% of infants, with a minority of them having an organic explanation. Failure to thrive and/or severe malnutrition are found in 3-5% of infants in this population. The objective of this study was to analyze the risk factors of feeding disorders in infants and children less than 3 years of age. This study was conducted from January 2011 to December 2014 and included 103 children, 57 with feeding and/or eating disorders and 46 healthy children considered to be normal eaters. Parents participated in a structured interview and completed a data sheet to record the mode of delivery, neonatal status, medical history, milk feeding, and medical treatment. Statistical analysis indicated that cesarean delivery, prematurity, neonatal diseases, history of eating disorders in the family, consumption of protein hydrolysates, and treatment with proton pump inhibitors were highly significant risk factors in children with eating disorders. In the present study, we showed that several prenatal and postnatal conditions or interventions were associated with the development of eating disorders in young children. Recommendations for future studies include identifying environmental risk factors and implementing prevention programs focused on family, caregivers, as well as healthcare professionals. The objective is to allow physicians to efficiently sort out the wide variety of conditions, categorize them for therapy, and when necessary refer patients to specialists in the field.


Subject(s)
Feeding and Eating Disorders/epidemiology , Case-Control Studies , Cesarean Section/statistics & numerical data , Child, Preschool , Female , France/epidemiology , Humans , Infant , Infant, Newborn , Infant, Newborn, Diseases , Male , Premature Birth , Protein Hydrolysates/administration & dosage , Proton Pump Inhibitors/administration & dosage , Risk Factors
13.
Arch Pediatr ; 23(12S): 12S15-12S20, 2016 Dec.
Article in French | MEDLINE | ID: mdl-28231889

ABSTRACT

In cystic fibrosis (CF), approximately 5-8% of the patients develop multilobular cirrhosis during the first decade of life. Annual screening (clinical examination, liver biochemistry, ultrasonography) is recommended in order to identify early signs of liver involvement, initiate ursodeoxycholic acid therapy and detect complications (portal hypertension and liver failure). Management should focus on nutrition and prevention of variceal bleeding. The gut may also be involved in children with CF. Gastroesophageal reflux is frequent, although often neglected and should be investigated by pH monitoring and impedancemetry, if available. Acute pancreatitis occurs in patients with persistent exocrine pancreatic activity. Intussusception, appendicular mucocele, distal intestinal occlusion syndrome, small bowel bacterial overgrowth and Clostridium difficile colitis should be considered in case of abdominal pain. Preventive nutritional support should be started as soon as possible after diagnosis of CF. Attainment of normal growth is one of the main goals and can be achieved with hypercaloric and salt supplemented food. Pancreatic enzyme replacement therapy should be started as soon as exocrine pancreatic insufficiency is confirmed and ingested immediately prior to meals with intake of fat-soluble vitamins. Curative nutritional interventions are more likely to be effective in the early stages of pulmonary disease. Feeding disorders, related to the physiopathology and the psychologic aspects of the disease are frequent. Repeated corporeal aggressions, associated with inappropriate medical and parental pressure, may increase the child's refusal of food. The multidisciplinary team should guide parents in order to avoid all intrusive feeding practices and promote pleasant mealtimes.


Subject(s)
Cystic Fibrosis/complications , Cystic Fibrosis/therapy , Digestive System Diseases/etiology , Digestive System Diseases/therapy , Feeding and Eating Disorders of Childhood/etiology , Feeding and Eating Disorders of Childhood/therapy , Liver Cirrhosis/etiology , Liver Cirrhosis/therapy , Child , Child, Preschool , Combined Modality Therapy , Cystic Fibrosis/diagnosis , Digestive System Diseases/diagnosis , Early Diagnosis , Early Medical Intervention , Feeding and Eating Disorders of Childhood/diagnosis , Humans , Infant , Interdisciplinary Communication , Intersectoral Collaboration , Liver Cirrhosis/diagnosis , Parent-Child Relations
14.
Arch Pediatr ; 23(12S): 12S47-12S53, 2016 Dec.
Article in French | MEDLINE | ID: mdl-28231894

ABSTRACT

Since the discovery of chloride secretion by the Cystic Fibrosis Transport regulator CFTR in 1983, and CFTR gene in 1989, knowledge about CFTR synthesis, maturation, intracellular transfer and function has dramatically expanded. These discoveries have led to the distribution of CF mutations into 6 classes with different pathophysiological mechanisms. In this article we will explore the state of art on CFTR synthesis and its chloride secretion function. We will then explore the consequences of the 6 classes of mutations on CFTR protein function and we will describe the new therapeutic developments aiming at correcting these defects.


Subject(s)
Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis/genetics , Cystic Fibrosis/therapy , DNA Mutational Analysis , Chlorides/metabolism , Cystic Fibrosis/physiopathology , Cystic Fibrosis Transmembrane Conductance Regulator/physiology , Humans
15.
Arch Pediatr ; 22(12): 1240-6, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26596857

ABSTRACT

BACKGROUND: Pseudomonas aeruginosa and Staphylococcus aureus toothbrush contamination in cystic fibrosis (CF) is unknown. This pilot study aimed to determine their prevalence and the potential involvement of toothbrushes in pulmonary infection. METHODS: Toothbrush bacteriological analysis for children aged 8-18 years was conducted on 27 CF patients, 15 healthy siblings, and 15 healthy children from the general population. RESULTS: S. aureus was detected on 22% of the patients' toothbrushes, and 13% of healthy children's toothbrushes and P. aeruginosa on 15% of patients' toothbrushes and 0-13% of healthy children's toothbrushes. There was no statistical correlation between pulmonary colonization and toothbrush contamination. P. aeruginosa genotyping showed two identical clones on the patients' toothbrushes and in their sputum, and between one patient's sputum and his sibling's toothbrush. CONCLUSION: S. aureus and P. aeruginosa can colonize CF patients' toothbrushes. The impact on pulmonary colonization remains unknown. Toothbrush decontamination methods need to consider these bacteria in CF patients.


Subject(s)
Cystic Fibrosis , Dental Devices, Home Care/microbiology , Equipment Contamination , Pseudomonas aeruginosa/isolation & purification , Staphylococcus aureus/isolation & purification , Adolescent , Child , Female , Humans , Lung/microbiology , Male , Pilot Projects , Sputum/microbiology
16.
Rev Mal Respir ; 32(6): 566-85, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26001957

ABSTRACT

INTRODUCTION: The gastrointestinal tract is a major source of morbidity in adults with cystic fibrosis (CF), with a wide range of complications, some of them being specific to the underlying disease. STATE OF KNOWLEDGE: Abnormal CFTR function, with reduced bicarbonate and other ion transport levels through the apical surface of epithelial cells, affects the intestinal tract including the pancreas and the liver. Similarly to what is observed in the respiratory tract, gastrointestinal CFTR dysfunction leads to mucus accumulation, dysmotility, small bowel bacterial overgrowth and inflammation with alteration of innate immune responses, all of which being likely to be interrelated. In developed countries, almost half of patients with CF are adults followed in multidisciplinary CF care centres by pneumologists who often have to manage gastrointestinal complications. CONCLUSION: It therefore appears essential that adult gastroenterologists develop the expertise needed for managing CF gastrointestinal complications in close collaboration with multidisciplinary CF care centre teams to improve the quality of life of adults with CF.


Subject(s)
Cystic Fibrosis/complications , Cystic Fibrosis/therapy , Gastrointestinal Diseases/therapy , Liver Diseases/therapy , Pancreatic Diseases/therapy , Adult , Biliary Tract Diseases/epidemiology , Biliary Tract Diseases/etiology , Biliary Tract Diseases/therapy , Cystic Fibrosis/epidemiology , Gastrointestinal Diseases/epidemiology , Gastrointestinal Diseases/etiology , Humans , Liver Diseases/epidemiology , Liver Diseases/etiology , Neoplasms/epidemiology , Neoplasms/etiology , Neoplasms/therapy , Pancreatic Diseases/epidemiology , Pancreatic Diseases/etiology
17.
Placenta ; 36(1): 34-40, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25468541

ABSTRACT

INTRODUCTION: Dietary supplementation with omega-3 long chain polyunsaturated fatty acids (n-3 PUFAs) may exert benefits in pregnancy through inhibition of placental inflammation. However, studies on the anti-inflammatory effects of n-3 PUFAs in the placenta are lacking. We compared the cytokine responses of human placental explants in vitro after 4 days pre-incubation with either: a) individual n-3 or n-6 PUFAs (20 µM), or b) physiologically relevant combinations of low, medium or high n-3 or n-6 PUFA concentrations. METHODS: Placental cytokine (IL-6 and TNF-α) mRNA expression and protein production were assessed at 4 h and 12 h, respectively. Cytokine and fatty acid concentrations were also measured in placentas delivered at term by women who ingested either low (n = 12) or high (n = 10) amounts of fish/fish oil in the month prior to delivery. RESULTS: Pre-exposure to n-3 PUFAs as individual fatty acids results in reduced placental IL-6 production (P < 0.05), whereas exposure to complex fatty acid mixtures enriched in n-3 PUFAs (high n-3:n-6 ratios) results in a significant stimulation of IL-6 production (P < 0.05). There were no differences in placental n-3 or n-6 PUFA levels between women with either high or low dietary fish oil intake and no differences in cytokine expression. DISCUSSION: In summary, data from our complex lipid explant model and an observational cohort study do not support a role for n3 PUFAs in the suppression of pro-inflammatory cytokine expression in the human placenta. Results from studies of placental tissues exposed to single n-3 and n-6 PUFAs should be interpreted with considerable caution.


Subject(s)
Fatty Acids, Omega-3/pharmacology , Fatty Acids, Omega-6/pharmacology , Interleukin-6/metabolism , Placenta/drug effects , Tumor Necrosis Factor-alpha/metabolism , Adult , Dietary Supplements , Female , Humans , Oxidative Stress/drug effects , Placenta/metabolism , Pregnancy , Young Adult
18.
Arch Pediatr ; 22(1): 32-8, 2015 Jan.
Article in French | MEDLINE | ID: mdl-25500066

ABSTRACT

Digestive complications related to the ingestion of magnetic foreign bodies in children are increasing, especially in Asia and North America. In France, several case reports have been reported since 2008. We conducted a retrospective multicentric study to evaluate the frequency of ingestion of magnet foreign bodies and to describe the complicated cases that have occurred in France over the last 5 years. We report 40 cases of which 60% were multiple magnet ingestions. Eighty-eight percent of the children of the group who had swallowed multiple magnets needed interventional management by endoscopy (33%) or surgery (58%). Only two children (12.5%) of the group who swallowed one magnet required removal. This problem is not uncommon in France (2% of the 1132 foreign bodies investigated in the Toulouse center over 5 years), which justifies clear information for healthcare professionals and caregivers in order to avoid potential intestinal complications. We suggest interventional management or very close monitoring in the cases of multiple magnet ingestion. Meanwhile, in the majority of confirmed cases of simple magnet ingestions, we propose home monitoring.


Subject(s)
Foreign Bodies/epidemiology , Foreign Bodies/surgery , Magnets , Age Distribution , Child , Child, Preschool , Endoscopy/statistics & numerical data , Female , France/epidemiology , Humans , Infant , Laparoscopy/statistics & numerical data , Male , Retrospective Studies , Sex Distribution
20.
Arch Pediatr ; 21(4): 372-6, 2014 Apr.
Article in French | MEDLINE | ID: mdl-24630904

ABSTRACT

The Script Concordance Test (SCT) is a tool used to evaluate clinical reasoning in complex medical situations. Our aim was to create the first SCT in pediatric gastroenterology in order to objectively assess medical students. We elaborated a SCT including 31 items divided into ten clinical cases. Topics were chosen within the list comprising the national academic exam. In order to assess medical students, a reference panel was made up of ten residents to establish the scoring process. Answers were noted on a Likert scale, ranging from -2 to +2. Scores were calculated based on the modal response. Depending on the variation of the experts' answers to each item, we classified the questions as correct, incorrect, or uncertain. The SCT was also taken by five GI pediatricians. The results were given as mean/20 ± SEM. The Student t-test was used for the statistical analysis. The scores were 15.35 ± 0.38 and 12.44 ± 0.58 (P=0.0006), respectively, for the reference panel and the students. Scores were unchanged by removing incorrect and uncertain questions. However, the score of the GI pediatricians was 13.37 ± 0.69, significantly lower than the reference panel (P=0.01). The reliability of this SCT is subject to debate. This was the first time the students had taken a SCT, but they considered that this tool was appropriate and in concordance with the objectives. Although the SCT is a useful method, its elaboration can be difficult. It seems important to create a group of teachers to validate the process and eliminate the wide variability.


Subject(s)
Clinical Competence , Educational Measurement/methods , Gastroenterology , Internship and Residency , Pediatrics/education , Students, Medical , Adult , Clinical Competence/standards , Female , Humans , Male , Reproducibility of Results , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL
...